PharmiWeb.com - Global Pharma News & Resources

Conference - Events

In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products. Whether you’re looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if you’re seeking to understand how gene therapy analytics differ from other biologics you’ve worked on in the past, this focused, technical event will provide insights specifically on the unique analytical challenges posed by gene therapy vectors, delivered by ‘boots on the ground’ scientists grappling with these challenges first-hand. Join…
Gene Therapy Analytical Development Europe
18-May-2021 - 19-May-2021
With the ability to generate large amounts of data, bioinformatics has emerged as key in all areas of cancer research from genome sequencing, transcriptome analysis, single cell analysis, cellular imaging and biomarker discovery.  This meeting will cover the latest advances in the field, focusing on analytic methods and new technologies to probe cancer cells and tissue at unprecedented resolution.
Pharmaceuticals, medical device and life science organizations of all sizes have executed digital initiatives at a greater scale in 2020, and continuing through 2021. Marketers do a good job showing how channels reach customers with leading KPIs, but how good a job are we doing demonstrating and actually measuring the impact of digital initiatives on business, especially across channels? There are many KPIs and channels that can be utilized. However, if senior leadership is not asking the right questions - it becomes increasingly difficult to understand where to make investments or deliver commercial transformation to actually deliver and measure ROI. Today, there are more questions than answers:What are the shortfalls, and are there more strategic analytical roadmaps for success as an ind…
2nd Annual | Re: Imagine Pharma Marketing
18-May-2021 - 20-May-2021
Running digitally for 2021, the 3rd Treg Directed Therapies Summit is the industry-led meeting focused on targeting and translating Treg modifying therapies with enhanced persistence and durability safely and at scale. Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to discuss how to robustly modify the Treg response through novel gene engineering and ensure scale and efficiency of cell sorting and isolation for effective cell expansion. Navigate across 3 days packed with dedicated, interactive formats exploring how to optimize and bring to clinic Treg directed therapies to address huge unmet medical need in autoimmune, allergic, transplant, inflammatory indications. https://treg-directed-therapies.com/ 18-20 May…
3rd Treg Directed Therapies Summit
The inaugural virtual Medical Device Software Development Summit, will unite 80+ senior medical device software architects, cyber security and human factors experts this May to strategize the design, development and validation of software that is innovative, compliant and secure. Hear real-life case studies, discussions and experiences from companies such as Philips, Boston Scientific and UCB on: - How to accelerate software development with agile methodologies- ISO standards and risk management to protect against cyber risks- Why usability is an integral part of your device development program - and how it can cost you millions if not done right- EU MDR and FDA compliance This is the chance to learn, network, address your major challenges and find answers to the most pressing medical devi…
Medical Device Software Development Summit
The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality, but our future. With pandemic vaccines now launching at record speeds, the first Genetic Vaccine Development for Infectious Diseases Summit will focus on overcoming the translational and clinical challenges of developing genetic vaccines targeting infectious diseases, including Influenza, Lassa fever, Ebola, MERS, HIV, Zika, and COVID-19.
Genetic Vaccine Development for Infectious Diseases Summit - May 2021 - Digital Event
17-May-2021 - 18-May-2021
Co-Chairs and Keynotes Include:- Dr Ann Daugherty, Genentech, Co-Chair- Dr James Cunningham, Allergan, Co-Chair- Dr Jeffrey Hubbell, University of Chicago, Keynote- Dr Robert Thorne, Denali Therapeutics, Keynote- Dr Kevin Healy, UC Berkeley, Keynote- Dr Sarah Hymowitz, Genentech, Keynote Key Topic Areas for 2020- Immunotherapy Drug Delivery Emerging Opportunities- Antibody and Enzyme Transport Vehicles: Delivering Large Molecules Across the Blood Brain Barrier- Intersections Between Drug Delivery and Regenerative Medicine- Challenges and Opportunities to Improve CNS Delivery- Delivery of Targeted Therapeutics and Nucleic Acids- AI/Machine Learning and The Impact on Drug Delivery- Advancing the Connected and Smart Drug Delivery Ecosystem- Novel SubQ Drug Delivery Approaches for Biotherapeut…
Drug Delivery West
SMi's 21st Pain Therapeutics Conference will focus on looking into research within pain therapeutics. In particular, the long-term (HEAL) initiative will be discussed and its role in advancing research to reduce the risks of opioid use and misuse and improve pain management, thereby reducing reliance on opioids and the national opioid public health crisis. Talks will also address the importance of sex, gender and race in pain research, including biomarkers, molecular targets, clinical and experimental models of pain. The conference also address cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies, with a focus on highlighting the importance of biomarker discovery and its contribution to early stage studies on pain. This will be…
SMi's 21st Annual Pain Therapeutics Conference
The 4th Annual Global Clinical Trials Connect 2021 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management. The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, e…
4th Annual Global Clinical Trials Connect 2021
04-May-2021 - 06-May-2021
L’effetto della pandemia sugli studi clinici è stato profondo.Ha portato alla compressione di decenni di piccoli passi di trasformazione digitale e ad una accelerazione nell’adozione di strategie innovative che hanno impattato tutti i processi attraverso i quali si conduce uno studio clinico: dalla fattibilità, al reclutamento dei pazienti, alla gestione del farmaco e all’analisi delle metriche e dei dati in tempo reale.A livello internazionale vengono condotti già da tempo gli studi decentralizzati: protocolli che prevedono una presenza molto limitata dei pazienti presso il centro clinico, proprio per ovviare a una delle principali cause di drop-out dalle sperimentazioni, ossia la difficoltà ad affrontare frequenti spostamenti per visite e controlli.Questo passaggio, impensabile fino a po…
Italian ePharma Day
The Psychedelic Therapeutics and Drug Development Conference has been organized to bring together the world's leading researchers and leaders in academia and industry to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder. Conference Themes: Clinical trial designRisk Evaluation and Mitigation Strategy (REMS)Abuse potentialPractical use/indications/DEA licensure and policy considerationsTarge…
The Psychedelic Therapeutics and Drug Development Conference
The future of cell therapies is multi-faceted. At the Multi-Functional Cell Therapies Summit, we gather pioneers at the forefront of development to discuss the next generation of cell therapies, which boast safer, more efficacious targeting profiles. Join Global Innovators to: - Investigate and overcome relapse and resistance: leverage functional analysis, novel combination strategy, and dual-CAR approaches with Kite: A Gilead Company, In8bio and Leucid Bio Ltd. - Harness the power of multiple cell types: from NK to gamma delta to TILs, using combination and hybrid modalities developed by Eureka Inc., NKarta Therapeutics and Iovance Biotherapeutics - Implement logic and develop 'decision-making' cells: create robust, controllable activation in vivo with University of Pennsylvania and Ludwi…
Multi-Functional Cell Therapies Summit
Conference: 28 – 29 April 2021Workshops: 27 April 2021Virtual Conference: Online Access Only Sponsor: Microcoat Chaired by: Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel   Biologic products require diligent microbial control because of their complex and sometimes growth-promoting manufacturing processes, and high-risk patient populations. The increase in complexity of pharmaceutical products, rise in development of biologics and increasingly stringent regulations for biologics are some of the factors that are driving the growth of the pharmaceutical microbiology market for biopharmaceutical products. SMi Group invite all microbiologists to join the virtual conference to discuss Contamination Control Strategies, Effective Environmental Monitoring, and the newest s…
SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference 
With the entire world's attention focused firmly on pulmonary fibrosis in the wake of COVID19 and the landmark INBUILD study dramatically overhauling the ILD drug development landscape, biopharma are finally on the cusp of developing and disseminating life-changing therapeutics for patients suffering with interstitial lung disease. Built from meticulous research with a faculty of world-renowned lung fibrosis heavyweights including Boehringer Ingelheim, Novartis, Roche, Abbvie, AdAlta and more, the inaugural Interstitial Lung Disease Drug Development Summit is the only industry focused forum giving you access to the ground-breaking research and radical insights you need to re-energize and revolutionize your drug development strategy against the next pulmonary fibrosis frontier. Across 3 uni…
Interstitial Lung Disease Drug Development Summit
SMi are proud to announce the 8th Pre-filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry. This comprehensive overview will help attendees understand the changing global market and the challenges faced within the industry. The upcoming conference will cover key topics driving the industry including advancing development for drug de…
Pre-Filled Syringes East Coast 2021 - Virtual conference: Online access only